http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002540797-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D205-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-10 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-01 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D205-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-10 |
| filingDate | 1999-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2002-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2002540797-A |
| titleOfInvention | Of 1- (4-fluorophenyl) -3 (R)-[3 (S) -hydroxy-3- (4-fluorophenyl) propyl)]-4 (S)-(4-hydroxyphenyl) -2-azetidinone Stereoselective microbial reduction for preparation |
| abstract | (57) [Summary]nA process for the stereoselective microbial reduction of a compound of formula (II) to a compound of formula (I), wherein the compound of formula (II) is treated in a medium, a medium and a buffer, a medium and a solvent, or Microorganisms, preferably Rhodococcus fascians ATCC No. 1 in a mixture of medium and buffer and solvent. 202210 or the fungal isolate Geotrichum candidum ATCC No. No. 74487, a process comprising incubating the resulting mixture and isolating the hydroxy compound of formula (I) is described. The compounds of formula (I) are serum cholesterol lowering agents. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010529148-A |
| priorityDate | 1999-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 67.